BioSpace News Archive

Specialty health care communications firm honored for comprehensive campaign

Kali, Inc. today announced publishing a new website and hosting an online shareholder presentation from the new website.

Sales event taking place from Thursday, Nov. 22 through Saturday, Nov. 24.

Topline results show reduction in LGCS, a standard measure in this indication, at 3 months from baseline

Newly-developed website to serve as a resource for Asia-Pacific (APAC) medical device sponsors.

Swedish Orphan Biovitrum AB today announce that the US Food and Drug Administration (FDA) has approved Gamifant® (emapalumab-lzsg), an interferon gamma (IFNγ) blocking antibody for the treatment of paediatric (new born and older) and adult patients with primary haemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance to conventional HLH therapy.

Leading Teen Treatment Group Offers Innovative Conferences in Cities Across the U.S.

truMedic announced today that the IS-4000 InstaShiatsu + Foot Massager with Heat is included in this year’s Oprah’s Favorite Things holiday gift list featured in the December issue of O, The Oprah Magazine and on OprahMag.com.

The U.S. Food and Drug Administration today approved Gamifant (emapalumab) for the treatment of pediatric (newborn and above) and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) who have refractory, recurrent or progressive disease or intolerance with conventional HLH therapy.

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer, today announced three upcoming poster presentations at the 60th annual meeting of the American Society of Hematology.